vs
AMICUS THERAPEUTICS, INC.（FOLD）与Childrens Place, Inc.（PLCE）财务数据对比。点击上方公司名可切换其他公司
Childrens Place, Inc.的季度营收约是AMICUS THERAPEUTICS, INC.的1.8倍（$339.5M vs $185.2M），AMICUS THERAPEUTICS, INC.净利率更高（0.9% vs -1.3%，领先2.2%），AMICUS THERAPEUTICS, INC.同比增速更快（23.7% vs -13.0%），AMICUS THERAPEUTICS, INC.自由现金流更多（$16.0M vs $-3.4M），过去两年AMICUS THERAPEUTICS, INC.的营收复合增速更高（29.5% vs -13.6%）
Amicus Therapeutics是总部位于美国宾夕法尼亚州费城的生物制药上市企业，2007年在纳斯达克挂牌上市，股票代码为FOLD。上市前，公司曾获得Radius Ventures、迦南合伙人、恩颐投资等多家风险投资机构的资金支持，专注于生物医药领域的研发与商业化布局。
Children’s Place是专业儿童服饰零售商，产品主要以旗下自有品牌发售，涵盖Gymboree、Sugar & Jade、PJ Place、Crazy 8等。目前该品牌在美国、加拿大、波多黎各共开设约525家门店，同时通过两个线上渠道以及15个国家的5家加盟合作伙伴开展销售，产品涵盖上衣、裙装、鞋履、裤装、睡衣、背包等全品类儿童服饰配件。
FOLD vs PLCE — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $185.2M | $339.5M |
| 净利润 | $1.7M | $-4.3M |
| 毛利率 | 85.7% | 33.1% |
| 营业利润率 | 8.6% | 1.1% |
| 净利率 | 0.9% | -1.3% |
| 营收同比 | 23.7% | -13.0% |
| 净利润同比 | -88.5% | -121.5% |
| 每股收益（稀释后） | $0.00 | $-0.19 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $185.2M | $339.5M | ||
| Q3 25 | $169.1M | $298.0M | ||
| Q2 25 | $154.7M | $242.1M | ||
| Q1 25 | $125.2M | $408.6M | ||
| Q4 24 | $149.7M | $390.2M | ||
| Q3 24 | $141.5M | $319.7M | ||
| Q2 24 | $126.7M | $267.9M | ||
| Q1 24 | $110.4M | $455.0M |
| Q4 25 | $1.7M | $-4.3M | ||
| Q3 25 | $17.3M | $-5.4M | ||
| Q2 25 | $-24.4M | $-34.0M | ||
| Q1 25 | $-21.7M | $-8.0M | ||
| Q4 24 | $14.7M | $20.1M | ||
| Q3 24 | $-6.7M | $-32.1M | ||
| Q2 24 | $-15.7M | $-37.8M | ||
| Q1 24 | $-48.4M | $-128.8M |
| Q4 25 | 85.7% | 33.1% | ||
| Q3 25 | 88.5% | 34.0% | ||
| Q2 25 | 90.2% | 29.2% | ||
| Q1 25 | 90.7% | 28.5% | ||
| Q4 24 | 90.1% | 35.5% | ||
| Q3 24 | 90.6% | 35.0% | ||
| Q2 24 | 91.1% | 34.6% | ||
| Q1 24 | 87.7% | 21.8% |
| Q4 25 | 8.6% | 1.1% | ||
| Q3 25 | 20.3% | 1.4% | ||
| Q2 25 | -6.1% | -10.0% | ||
| Q1 25 | -6.3% | 1.7% | ||
| Q4 24 | 10.7% | 7.5% | ||
| Q3 24 | 15.3% | -6.8% | ||
| Q2 24 | 11.8% | -10.4% | ||
| Q1 24 | -25.1% | -13.6% |
| Q4 25 | 0.9% | -1.3% | ||
| Q3 25 | 10.2% | -1.8% | ||
| Q2 25 | -15.8% | -14.1% | ||
| Q1 25 | -17.3% | -2.0% | ||
| Q4 24 | 9.8% | 5.1% | ||
| Q3 24 | -4.8% | -10.0% | ||
| Q2 24 | -12.4% | -14.1% | ||
| Q1 24 | -43.9% | -28.3% |
| Q4 25 | $0.00 | $-0.19 | ||
| Q3 25 | $0.06 | $-0.24 | ||
| Q2 25 | $-0.08 | $-1.57 | ||
| Q1 25 | $-0.07 | $-0.60 | ||
| Q4 24 | $0.05 | $1.57 | ||
| Q3 24 | $-0.02 | $-2.51 | ||
| Q2 24 | $-0.05 | $-2.98 | ||
| Q1 24 | $-0.16 | $-10.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $293.5M | $7.3M |
| 总债务越低越好 | $392.7M | $107.4M |
| 股东权益账面价值 | $274.2M | $-8.6M |
| 总资产 | $949.9M | $762.5M |
| 负债/权益比越低杠杆越低 | 1.43× | — |
8季度趋势，按日历期对齐
| Q4 25 | $293.5M | $7.3M | ||
| Q3 25 | $263.8M | $7.8M | ||
| Q2 25 | $231.0M | $5.7M | ||
| Q1 25 | $250.6M | $5.3M | ||
| Q4 24 | $249.9M | $5.7M | ||
| Q3 24 | $249.8M | $9.6M | ||
| Q2 24 | $260.1M | $13.0M | ||
| Q1 24 | $239.6M | $13.6M |
| Q4 25 | $392.7M | $107.4M | ||
| Q3 25 | $392.0M | $107.2M | ||
| Q2 25 | $391.3M | $107.0M | ||
| Q1 25 | $390.7M | $166.0M | ||
| Q4 24 | $390.1M | $165.7M | ||
| Q3 24 | $389.5M | $165.4M | ||
| Q2 24 | $388.9M | $166.6M | ||
| Q1 24 | $388.4M | $49.8M |
| Q4 25 | $274.2M | $-8.6M | ||
| Q3 25 | $230.4M | $-4.9M | ||
| Q2 25 | $204.3M | $1.4M | ||
| Q1 25 | $193.6M | $-59.4M | ||
| Q4 24 | $194.0M | $-49.6M | ||
| Q3 24 | $178.8M | $-68.9M | ||
| Q2 24 | $132.5M | $-34.9M | ||
| Q1 24 | $130.7M | $-9.0M |
| Q4 25 | $949.9M | $762.5M | ||
| Q3 25 | $868.8M | $805.1M | ||
| Q2 25 | $815.3M | $779.6M | ||
| Q1 25 | $789.8M | $747.6M | ||
| Q4 24 | $785.0M | $888.8M | ||
| Q3 24 | $786.6M | $921.4M | ||
| Q2 24 | $749.5M | $848.3M | ||
| Q1 24 | $721.8M | $800.3M |
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | 75.63× | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — | ||
| Q1 24 | 2.97× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $16.3M | $6.2M |
| 自由现金流经营现金流 - 资本支出 | $16.0M | $-3.4M |
| 自由现金流率自由现金流/营收 | 8.6% | -1.0% |
| 资本支出强度资本支出/营收 | 0.2% | 2.8% |
| 现金转化率经营现金流/净利润 | 9.62× | — |
| 过去12个月自由现金流最近4个季度 | $29.8M | $39.5M |
8季度趋势，按日历期对齐
| Q4 25 | $16.3M | $6.2M | ||
| Q3 25 | $35.7M | $-30.5M | ||
| Q2 25 | $-26.5M | $-43.0M | ||
| Q1 25 | $7.8M | $121.3M | ||
| Q4 24 | $-3.9M | $-44.2M | ||
| Q3 24 | $-23.0M | $-83.9M | ||
| Q2 24 | $22.7M | $-110.8M | ||
| Q1 24 | $-29.7M | $135.4M |
| Q4 25 | $16.0M | $-3.4M | ||
| Q3 25 | $35.3M | $-31.9M | ||
| Q2 25 | $-28.9M | $-46.4M | ||
| Q1 25 | $7.5M | $121.2M | ||
| Q4 24 | $-4.2M | $-47.7M | ||
| Q3 24 | $-23.3M | $-91.7M | ||
| Q2 24 | $21.6M | $-115.5M | ||
| Q1 24 | $-31.5M | $132.2M |
| Q4 25 | 8.6% | -1.0% | ||
| Q3 25 | 20.9% | -10.7% | ||
| Q2 25 | -18.7% | -19.2% | ||
| Q1 25 | 6.0% | 29.7% | ||
| Q4 24 | -2.8% | -12.2% | ||
| Q3 24 | -16.5% | -28.7% | ||
| Q2 24 | 17.0% | -43.1% | ||
| Q1 24 | -28.5% | 29.1% |
| Q4 25 | 0.2% | 2.8% | ||
| Q3 25 | 0.2% | 0.5% | ||
| Q2 25 | 1.6% | 1.4% | ||
| Q1 25 | 0.2% | 0.0% | ||
| Q4 24 | 0.2% | 0.9% | ||
| Q3 24 | 0.3% | 2.4% | ||
| Q2 24 | 0.9% | 1.8% | ||
| Q1 24 | 1.6% | 0.7% |
| Q4 25 | 9.62× | — | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.27× | -2.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
PLCE
| The Childrens Place US | $307.4M | 91% |
| The Childrens Place International | $32.1M | 9% |
| Gift Cards | $1.7M | 1% |
